By Admin at 23 Nov 2016
Gateway encourages you to participate in #GivingTuesday, a 1-day global philanthropic effort that provides the opportunity to give back.
By Administrator at 22 Nov 2016
According to new research, people who have genetic risk factors for colon cancer may be able to lower their risk significantly by leading a healthy lifestyle.
By Admin at 15 Nov 2016
Gateway for Cancer Research has teamed up with Amazon Smile to offer you a simple and automatic way to support Gateway’s mission every time you shop, at no cost to you.
By Admin at 11 Nov 2016
Cryoablation, or deep freezing, may represent the wave of the future for treating certain types of breast cancer. The procedure requires no hospitalization, takes less than 30 minutes and requires no recovery time — patients walk out of treatment with only a Band-Aid to show for it.
By Admin at 7 Nov 2016
A genetic test known as the 21-gene recurrence score assay (RS) measures the activity of genes that control cell growth and more. A high score on the test indicates a woman has a high risk of cancer recurrence and chemotherapy is recommended. A low score suggests chemotherapy can safely be skipped.
Current Gateway-funded clinical trials
Clinical trials funded at leading institutions worldwide
Funds one patient for one day at a Gateway-funded clinical trial